Paul Schimmel, Director at aTYR PHARMA INC (LIFE), bought 62,572 shares at $2.50 ($124K) on 2016-12-15, disclosed to the SEC on 2016-12-19.
Open-market purchase of $124k LIFE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 12,572 | $0 | 0.0% |
| 2 | $2.50 | 40,000 | $100K | 80.6% |
| 3 | $2.40 | 10,000 | $24K | 19.4% |
| Total | $1.98 avg | 62,572 | $124K | 100% |
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |